ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

2-(ジフェニルアセトキシ)エチルジエチルアミン

Adiphenine

HCID 2031
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
64-95-9
標準SMILES
CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1
InChIKey
JGOAIQNSOGZNBX-UHFFFAOYSA-N
分子式
C20H25NO2
平均分子量
311.4 g/mol
単同位体質量
311.18852904

概要

2,2-diphenylacetic acid 2-(diethylamino)ethyl ester is a diarylmethane.

名称と識別子

優先名称
Adiphenine
IUPAC
2-(diethylamino)ethyl 2,2-diphenylacetate
現地名
2-(ジフェニルアセトキシ)エチルジエチルアミン
英語名
adiphenine
分子式
C20H25NO2
分子量
311.42

名称と別名

adiphenineAdipheninDiphacilTranzetilTrasentinDifacil64-95-9PatrovineSpasmolytinTransentineDiphacylVegantine
名称をさらに表示
トラセンチンアジフェニンα-フェニルベンゼン酢酸2-(ジエチルアミノ)エチルジフェニル酢酸2-(ジエチルアミノ)エチルジフェニル酢酸2-ジエチルアミノエチルジファシルパトロビン2-(ジフェニルアセトキシ)エチルジエチルアミン2-(ジエチルアミノ)エチル 2,2-ジフェニルアセタートTrasentineAcedoben Impurity 72-(diethylamino)ethyl diphenylacetateDiphenylacetic acid 2-(diethylamino)ethyl2-diethylaminoethyl 2,2-di(phenyl)acetate2-diethylaminoethyl 2,2-di(phenyl)ethanoate
AdifeninaTrazentynaWegantyna2-(diethylamino)ethyl 2,2-diphenylacetateAdipheninumDiphenylacetyldiethylaminoethanol2-Diethylaminoethyl diphenylacetateDiphenylacetic acid diethylaminoethyl ester

データベース識別子

CAS
64-95-9

物性

構造計算による物性

XLogP
4.2
極性表面積
29.5 Ų
水素結合供与体数
0
水素結合受容体数
3
回転可能結合数
9
重原子数
23
形式電荷
0
複雑度
311

実験および物理化学的性質

Human DrugsPharmaceuticals
DecompositionWhen heated to decomposition it emits toxic fumes of NOx.
Melting PointCrystals. MP: 113-114 °C; Readily soluble in water; very sparingly soluble in alcohol, ether /Hydrochloride/
Collision Cross Section175.23 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
113.5 °C · 113.5°C
沸点
451.46 °C · 451.46°C (rough estimate)
比重(密度)
1.0899 · 1.0899 (rough estimate)
屈折率
1.5614 · 1.5614 (estimate)
水溶解度
18.36 mg/L · 18.36mg/L(37℃)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Other Safety InformationIMAP assessments - Benzeneacetic acid, .alpha.-phenyl-, 2-(diethylamino)ethyl ester: Environment tier I assessment

安全と保護具

Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

毒性情報

Interactions · 2 件

ALTHOUGH THE DRUG IS RELATIVELY NONTOXIC, IT SHOULD NOT BE USED IN CLOSE SEQUENCE WITH MORPHINE; THE COMBINATION APPEARS TO CAUSE APPREHENSION & TACHYCARDIA. /ADIPHENINE HYDROCHLORIDE/

Spasmolytin (adiphenine hydrochloride) and tropicine were administered im to albino rats poisoned with anabasine sulfate doses of 346, 519, and 692 mg/kg administered through gastric tube. The LD50 of anabasine sulfate, determined for treatment with adiphenine hydrochloride, was 570 mg/kg, and 403 mg/kg for treatment with tropacine. The LD16 and LD84 values determined for treatment with adiphenine hydrochloride and tropacine were 460 and 712 mg/kg and 288 and 498 mg/kg, respectively. Adiphenine hydrochloride and tropacine, administered im in 20 mg/kg doses, reduced the LD50 of anabasine sulfate by 271% and 191%, respectively./Adiphenine hydrochloride/

Non-Human Toxicity Excerpts · 1 件

/ALTERNATIVE and IN VITRO TESTS/The mechanism of action of adiphenine on in vitro rat anterior pituitary TSH release was compared to that of the physiological stimulator TRH. The comparative study showed that adiphenine and TRH were able to increase TSH release in a dose-dependent manner, had similar time courses of action for equipotent stimulating concentrations and produced similar aspects of stimulated TSH cells. However, there were several differences between the effects of adiphenine and TRH. Adiphenine action was inhibited by 20 mM K+; was not calcium dependent; was inhibited by neither thyroid hormones nor somatostatin; was little affected by energy depression. It is concluded that adiphenine probably acts near the ultimate steps of the TSH release pathway and could be a useful pharmacological tool for studying the mechanism of TSH release.

化学と産業

薬理情報

Biological Half-Life · 1 件

Adiphenine was administered in 3H-labelled form in doses of 15 mumole/kg intravenously to male Wistar rats. Plasma and brain levels of the unchanged drug were measured. The elimination of the 3H-labelled compound from the plasma was monophasic with a half-life of 13 minutes. The unchanged drug was detectable in the plasma for 30 minutes after the injection. The time course of brain levels of unchanged drug paralleled that found in the plasma with a half-life of 9 to 12 minutes. In all experiments, brain and plasma levels of unchanged adiphenine correlate highly.

Metabolism/Metabolites · 2 件

Major metabolites isolated from rat urine after administration of a single dose of (14C)adiphenine or (3H)adiphenine were identified by chromatography and n.m.r. spectrometry, and by comparison with authentic reference compounds chemically synthesized. Adiphenine was extensively metabolized by hydrolysis of the ester bond into diethylaminoethanol, diphenylacetic acid, diphenylacetic acid glucuronide and, in small quantities, the corresponding glycine and glutamine conjugates.

The disposition of adiphenine labelled with 14C in two positions has been investigated in rats and mice after iv administration ... In preliminary metabolic studies, three major metabolites have been identified: diphenylacetic acid, diethylethanolamine and a diphenylacetic acid glucuronide.

Absorption, Distribution and Excretion · 2 件

This study describes the behavior of a dual labelled drug, adiphenine, in the rat brain. Macroautoradiographies show images of the brain at different times after injection. Some of the tissue metabolites are identified at the brain level and the passage of the blood brain barrier is compared with tritiated water. The obtained data give very interesting indications on the blood brain distribution and on the metabolism at the brain level. Different techniques of high pressure liquid chromatography, macro- and histoautoradiographies allowed /visualization of/ how the drug is fixed on cerebral structures, giving indications on its mechanism of action.

The disposition of adiphenine labelled with 14C in two positions has been investigated in rats and mice after iv administration, and has been compared with that of the [14C]diethylethanolamine HCl and of the [14C]diphenylacetic acid. Radioactivity in the blood declined in a biphasic manner. Biliary elimination depended upon the 14C-labelled compound administered: less than 5% dose for the diethylethanolamine moiety, 100% dose for the carboxylic moiety. Of the radioactivity appearing in rat bile, less than 1% is associated with unchanged adiphenine. ... Uptake by the brain of [14C]adiphenine shortly after dosing is 15 times greater than that of blood. Radioactivity is also found in the hypophysis, the adrenals and melanoid pigments, with a concentration up to 30 times greater than that found in the blood.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
2031
DTXSID
DTXSID0022561
ChEMBL
CHEMBL353846
ChEBI
CHEBI:94680
UNII
YKG6OR043Q
EC Number
200-599-0
Nikkaji
J4.836D
Antidote and Emergency Treatment · 3 件

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

Non-Human Toxicity Values · 5 件

LD50 rat intravenous 27 mg/kg

LD50 mouse oral 600 mg/kg

LD50 mouse subcutaneous 400 mg/kg

LD50 mouse intravenous 21.5 mg/kg

For more Non-Human Toxicity Values (Complete) data for ADIPHENINE (6 total), please visit the HSDB record page.

安全データ

有毒物質データの
64-95-9(Hazardous Substances Data)

用途と製造

Uses · 3 件

THERAP CAT: Antispasmodic

MEDICATION

MEDICATION (VET)

Methods of Manufacturing · 2 件

PREPD BY ACTION OF DIPHENYLACETYL CHLORIDE OR DIPHENYL KETENE ON DIETHYLAMINOETHANOL: SWISS PATENT 190,541 (1937 TO CIBA); GER PATENTS 626,539; 653,778 (1937). /ADIPHENINE HYDROCHLORIDE/

Preparation: DE 626539 (1936 to Ciba)

Use ClassificationPharmaceuticals
General Manufacturing InformationAntiacid for relief of gastric hyperacidity /Carmethose-Trasentine/ /Former/

応用分野

使用Relaxant (smooth muscle).

上流・下流製品情報

上流原料

2-ジエチルアミノエタノール塩化スルフィニル

サプライヤー6 社

陕西缔都医药化工有限公司029-029-81120477 17792793610 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
成都圣美凯生物科技有限公司028-85157043 15882256948 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]